Sonovue

Sonovue is a contrast agent containing sulfur hexafluoride microbubbles used in ultrasound imaging to enhance visibility of blood flow and tissue perfusion. It is administered intravenously or intravesically for diagnostic purposes. Suitable for patients undergoing contrast-enhanced ultrasound procedures.

Sulfur hexafluoride microbubbles in Sonovue improve the clarity of ultrasound images by increasing the reflection of sound waves. This helps healthcare professionals evaluate blood flow in organs, detect abnormalities, and assess vascular structures during diagnostic imaging. Sonovue is commonly used in cardiac, liver, and breast ultrasound studies.

Sonovue enhances the visibility of blood vessels and tissues during ultrasound imaging, making it easier to identify areas of interest. Patients may experience a brief sensation of warmth or mild discomfort at the injection site. These effects are typically short-lived and resolve quickly after administration.

Sonovue should only be used under the supervision of a qualified healthcare professional. Patients with known allergies to sulfur hexafluoride or any component of the product should avoid its use. Inform your doctor of any pre-existing conditions, especially heart or lung issues, before undergoing imaging with Sonovue.

No specific drug interactions have been widely reported with Sonovue. However, caution is advised when using other contrast agents or medications that may affect cardiovascular function. Always disclose all medications and supplements to your healthcare provider prior to imaging.